The Pharma & Healthcare market is expected to grow from USD 8.5 trillion in 2020 to USD 14.2 trillion by 2026, at a CAGR of 4.8% during the forecast period.
The Local Anesthesia Drugs Market is expected to grow from USD 3.43 Billion in 2025 to USD 4.77 Billion by 2032, at a CAGR of 4.90% during the forecast period.
The Live Attenuated Vaccines Market is expected to grow from USD 22.80 Billion in 2025 to USD 32.80 Billion by 2032, at a CAGR of 5.40% during the forecast period.
The Leukemia Therapeutics Market is expected to grow from USD 17.20 Billion in 2025 to USD 28.29 Billion by 2032, at a CAGR of 7.40% during the forecast period.
The Large Molecules Drug Substance CDMO Market is expected to grow from USD 20.60 Billion in 2025 to USD 41.70 Billion by 2032, at a CAGR of 10.60% during the forecast period.
The Lab Automation in Drug Discovery Market is expected to grow from USD 7.95 Billion in 2025 to USD 13.89 Billion by 2032, at a CAGR of 0.08% during the forecast period.
The Kidney Cancer Therapeutics & Diagnostics Market is expected to grow from USD 9.20 Billion in 2025 to USD 19.86 Billion by 2032, at a CAGR of 11.40% during the forecast period.
The GLP-1 Agonists Market is expected to grow from USD 47.20 Billion in 2025 to USD 155.00 Billion by 2032, at a CAGR of 18.70% during the forecast period.
The GIS Market is expected to grow from USD 13.30 Billion in 2025 to USD 28.20 Billion by 2032, at a CAGR of 11.20% during the forecast period.
The Genitourinary Drugs Market is expected to grow from USD 40.80 Billion in 2025 to USD 67.32 Billion by 2032, at a CAGR of 7.40% during the forecast period.
The Generic Drugs Market is expected to grow from USD 535.00 Billion in 2025 to USD 827.90 Billion by 2032, at a CAGR of 6.40% during the forecast period.
The Local Anesthesia Drugs Market is expected to grow from USD 3.43 Billion in 2025 to USD 4.77 Billion by 2032, at a CAGR of 4.90% during the forecast period.
The Live Attenuated Vaccines Market is expected to grow from USD 22.80 Billion in 2025 to USD 32.80 Billion by 2032, at a CAGR of 5.40% during the forecast period.
The Leukemia Therapeutics Market is expected to grow from USD 17.20 Billion in 2025 to USD 28.29 Billion by 2032, at a CAGR of 7.40% during the forecast period.
The Large Molecules Drug Substance CDMO Market is expected to grow from USD 20.60 Billion in 2025 to USD 41.70 Billion by 2032, at a CAGR of 10.60% during the forecast period.
The Lab Automation in Drug Discovery Market is expected to grow from USD 7.95 Billion in 2025 to USD 13.89 Billion by 2032, at a CAGR of 0.08% during the forecast period.
The Kidney Cancer Therapeutics & Diagnostics Market is expected to grow from USD 9.20 Billion in 2025 to USD 19.86 Billion by 2032, at a CAGR of 11.40% during the forecast period.
The GLP-1 Agonists Market is expected to grow from USD 47.20 Billion in 2025 to USD 155.00 Billion by 2032, at a CAGR of 18.70% during the forecast period.
The GIS Market is expected to grow from USD 13.30 Billion in 2025 to USD 28.20 Billion by 2032, at a CAGR of 11.20% during the forecast period.
The Genitourinary Drugs Market is expected to grow from USD 40.80 Billion in 2025 to USD 67.32 Billion by 2032, at a CAGR of 7.40% during the forecast period.
The Generic Drugs Market is expected to grow from USD 535.00 Billion in 2025 to USD 827.90 Billion by 2032, at a CAGR of 6.40% during the forecast period.